SciMed Biotech Podcast with Alice McConnell, CEO at Speragen
The Public Health Crisis Hiding Inside Newborn Screening
What happens when the technology to diagnose rare diseases exists, but the healthcare system still struggles to deliver it to patients? In this episode of the SciMed Biotech Podcast, Alice McConnell of Speragen shares how her family’s personal experience with rare disease led her to tackle the major gaps in newborn screening. The conversation explores why early diagnosis matters, the challenges of expanding screening programs across the U.S., and how outdated systems continue to leave families searching for answers. It’s an eye opening look at the intersection of diagnostics, public health, and patient advocacy.
